Nuvation Bio Inc.

NUVB · NYSE · SIC 2834: Pharmaceutical Preparations
90
SEC Filings

Business Summary

PART I . On February 10, 2021, (the Closing Date), Nuvation Bio Inc., a Delaware corporation (Legacy Nuvation Bio), Panacea Acquisition Corp. (Panacea), and Panacea Merger Subsidiary Corp, a Delaware corporation and a direct, wholly owned subsidiary of Panacea (Merger Sub) consummated the transactions contemplated by an Agreement and Plan of Merger among them dated October 20, 2020 (Merger Agreement). Pursuant to the terms of the Merger Agreement, a business combination of Panacea and Legacy Nuv...

Next Earnings

Q2 FY2026 — expected 2026-08-05

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNUVBdiscussed_in_filing Cybersecurity
topic_mentionNUVBdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001193125-26-085584EDGAR104K words
2025-03-062024-12-310000950170-25-034903EDGAR—
2024-02-292023-12-310000950170-24-023247EDGAR—
2023-03-152022-12-310000950170-23-008180EDGAR—
2022-02-282021-12-310000950170-22-002332EDGAR—
2021-03-112020-12-310001193125-21-077880EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-032025-09-300001193125-25-262605EDGAR77K words
2025-08-072025-06-300000950170-25-104626EDGAR—
2025-05-072025-03-310000950170-25-065712EDGAR—
2024-11-062024-09-300000950170-24-122402EDGAR—
2024-08-052024-06-300000950170-24-090347EDGAR—
2024-05-142024-03-310000950170-24-059622EDGAR—
2023-11-022023-09-300000950170-23-058253EDGAR—
2023-08-032023-06-300000950170-23-038155EDGAR—
2023-05-042023-03-310000950170-23-017926EDGAR—
2022-11-032022-09-300000950170-22-021943EDGAR—
2022-08-042022-06-300000950170-22-014868EDGAR—
2022-05-092022-03-310000950170-22-008530EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-020001193125-26-085474EDGAR5K words
2026-01-120001193125-26-009826EDGAR—
2025-11-260001193125-25-298551EDGAR—
2025-11-170001193125-25-284845EDGAR—
2025-11-030001193125-25-262576EDGAR—
2025-08-070001193125-25-174954EDGAR—
2025-06-110001193125-25-139164EDGAR—
2025-05-230001193125-25-125763EDGAR—
2025-05-070001193125-25-114908EDGAR—
2025-03-250001193125-25-062031EDGAR—

90 total filings indexed. 62 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001811063
TickerNUVB
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1648cf9611b886b44e0bd207ca07a14bfbcadaf1ed610be724273ff439c16d35
parent: 112100d25ebfe09b0d50b11a989cf97863dd410bb75bb014415b9deedfd9ef3a
content hash: 1be5256ef5afe7fc97b4754532b461b14885bd3efb62436fa3be16e591db4dcd
signed: 2026-04-13T04:46:37.118Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf